Atria Investments Inc Sells 2,740 Shares of Encompass Health Co. (NYSE:EHC)

Atria Investments Inc trimmed its position in Encompass Health Co. (NYSE:EHC) by 23.2% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 9,091 shares of the company’s stock after selling 2,740 shares during the period. Atria Investments Inc’s holdings in Encompass Health were worth $879,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in EHC. Magnetar Financial LLC grew its holdings in shares of Encompass Health by 1,176.6% in the second quarter. Magnetar Financial LLC now owns 744,836 shares of the company’s stock valued at $63,899,000 after acquiring an additional 814,018 shares in the last quarter. Thrivent Financial for Lutherans boosted its holdings in shares of Encompass Health by 2,302.7% in the 2nd quarter. Thrivent Financial for Lutherans now owns 603,558 shares of the company’s stock worth $51,780,000 after buying an additional 578,438 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Encompass Health by 614.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 540,519 shares of the company’s stock worth $44,637,000 after buying an additional 464,897 shares during the last quarter. Epoch Investment Partners Inc. raised its position in Encompass Health by 14.2% in the first quarter. Epoch Investment Partners Inc. now owns 1,598,042 shares of the company’s stock worth $131,966,000 after acquiring an additional 198,701 shares during the period. Finally, Vanguard Group Inc. boosted its stake in Encompass Health by 1.7% in the first quarter. Vanguard Group Inc. now owns 10,166,147 shares of the company’s stock valued at $839,520,000 after acquiring an additional 169,113 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. UBS Group lifted their price target on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, September 25th. Truist Financial reaffirmed a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. KeyCorp lifted their price objective on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Barclays raised their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, Stephens reissued an “overweight” rating and set a $105.00 target price on shares of Encompass Health in a report on Tuesday, August 6th. Nine equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Stock Down 2.3 %

Shares of NYSE:EHC opened at $98.85 on Monday. The firm has a fifty day moving average price of $96.38 and a two-hundred day moving average price of $90.35. The company has a market cap of $9.96 billion, a price-to-earnings ratio of 23.88, a PEG ratio of 1.31 and a beta of 0.88. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. Encompass Health Co. has a one year low of $63.59 and a one year high of $104.55.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm’s revenue was up 11.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.86 earnings per share. Analysts anticipate that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is 16.43%.

Encompass Health declared that its board has approved a share buyback program on Wednesday, July 24th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to buy up to 5.4% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s board of directors believes its shares are undervalued.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.